A Study to Assess the Pharmacokinetics and Safety of CSL312 in Healthy Japanese and Caucasian Adults

Clinical trial NCT04580654 · COMPLETED

Trial details

NCT number: NCT04580654
Sponsor: CSL Behring
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2020-10-29
Primary completion: 2021-05-07
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.